§ Funding Round
Series B funding round for Prellis Biologics raising $15M in December 2021
Series B funding round for Prellis Biologics raising $15M in December 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Buckley Ventures | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Saga | — | — |
| Organization | — | |
| Angel | alexander gerko | |
| Angel | louis beryl | |
| Angel | matt bellamy | |
| Angel | mattia astori | |
| Angel | Michael Moritz | |
| Angel | Paul Graham | |
| Angel | sahin boydas | |
| Angel | Sam Altman | |
kevin chapmanLEAD | Angel | kevin chapman |
| Organization | — | |
Khosla VenturesLEAD | Organization | — |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$83.1M
Top Valuation
-
Prellis Biologics raised $15M in a Series B round.
The round was announced on 12/01/21.
The round was led by kevin chapman, Khosla Ventures.
